Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

Presentation THT 2022

scPharma

Presenter: Daniel Bensimhon

February 01, 2022

Presentation THT 2022

WhiteSwell

Presenter: Sitaramesh Emani

February 01, 2022

Presentation THT 2022

3ive

Presenter: David Baran

February 01, 2022

Presentation THT 2022

Cardionomic

Presenter: Sitaramesh Emani

February 01, 2022

Presentation THT 2022

AquaPass

Presenter: Doron Aronson

February 01, 2022

Presentation THT 2022

Reprieve

Presenter: Jeffrey Testani

February 01, 2022

Presentation THT 2022

Pullers: Revamp and Precardia

Presenter: Ulrich Jorde

February 01, 2022

Presentation THT 2022

Pushers: Aortix and Second Heart

Presenter: Palak Shah

February 01, 2022

Presentation THT 2022

EMPULSE: The Use of SGLT2 Inhibitors in Acute Decompensated Heart Failure

Presenter: Piotr Ponikowski

February 01, 2022

Presentation THT 2022

Overview of ADHF (DRIIPPS)

Presenter: James Udelson

February 01, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Moderator Led Discussion

Presenter: JoAnn Lindenfeld

February 01, 2022

Presentation THT 2022

Moderator Led Discussion

Presenter: Ulrich Jorde

February 01, 2022

Presentation THT 2022

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Liviu Klein

February 01, 2022

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

Presentation THT 2022

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Presenter: Alanna Morris

February 01, 2022

Presentation THT 2022

Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease

Presenter: Ryan Tedford

February 01, 2022

Presentation THT 2022

Timing of Intervention and the fate of the RV

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

Why should we do this?

Presenter: William Abraham

February 01, 2022

Advertisement

scPharma

WhiteSwell

3ive

Cardionomic

AquaPass

Reprieve

Pullers: Revamp and Precardia

Pushers: Aortix and Second Heart

EMPULSE: The Use of SGLT2 Inhibitors in Acute Decompensated Heart Failure

Overview of ADHF (DRIIPPS)

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Moderator Led Discussion

Moderator Led Discussion

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease

Timing of Intervention and the fate of the RV

Why should we do this?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content